Search Results

Canada's Cameco Signs Exclusive Offtake Agreement to Lock Up All Future Output from U.S. Paducah Laser Enrichment Plant

Canadian nuclear fuel giant Cameco has signed a new exclusive offtake agreement with Global Laser Enrichment (GLE), under which Cameco will purchase all nuclear fuel products from the future production of the Paducah Laser Enrichment Facility (PLEF) that GLE plans to build in Kentucky, United States. This major agreement was formally announced by Australia's Silex Systems. GLE was founded in 2007 to develop and commercialize laser-based uranium enrichment technology in the United States. The company is currently 51% owned by Silex Systems, the developer of SILEX laser enrichment technology, and 49% by Cameco. Silex Chief Executive Officer and Managing Director Mike...

2026-09-17

Canada Promotes Uranium Resources and Nuclear Industry to the UK

Recently, Scott Moe, Premier of the Canadian province of Saskatchewan, led a trade and investment delegation to the United Kingdom, focusing on promoting the province's abundant uranium resources and its expertise and experience in the nuclear energy sector. The visit aimed to demonstrate to the UK side that Saskatchewan possesses the resource reserves, research and development infrastructure, and complete industrial chain conditions to advance nuclear energy development, and to create opportunities for local enterprises to expand into overseas markets. Scott Moe stated in an official statement that the province has abundant uranium resources, well-established nuclear energy research infrastructure, and mature supply chain capabilities, and is fully equipped to become a world leader in nuclear energy development....

2026-09-14

Canada's CSMC Releases Three Advanced Nuclear Reactor Designs

On September 10, 2026, Canadian aerospace and defense company Canadian Strategic Missions Corporation (CSMC) released three advanced nuclear reactor platforms, namely Polar-1, Jay-1, and Orca-1. The company said these three reactors target different application scenarios including remote communities, military operations, space infrastructure, scientific research, testing, and personnel training. CSMC was founded in 2020. The company stated that the three platforms constitute its advanced nuclear technology portfolio, aiming to provide reliable and deployment-flexible nuclear energy solutions in environments where conventional energy solutions struggle to meet demand, with application areas including Arctic communities...

2026-09-13

Best Cyclotron Systems 70MeV high-current proton cyclotron passes factory acceptance test, to be delivered to Taiwan, China

Best Cyclotron Systems (BCS) recently announced that its 70 megaelectronvolt (MeV) high-current proton cyclotron B-70 completed factory acceptance testing in July, and the equipment will soon be delivered to the National Atomic Research Institute (NARI) in Taoyuan City, Taiwan, China. Related installation and project construction are expected to be completed in 2027. According to the introduction, B-70 was designed, developed and manufactured in Canada by engineers and scientists under TeamBest, and is an advanced cyclotron system for high-current proton beam applications. The equipment will be used to expand accelerator-based radioisotope production and research capabilities, and also reflects the company's...

2026-09-11

Canada's Nuclear Laboratories Adjusts Clean Energy Program to Support Deployment of New Nuclear Projects in Canada

On September 10, 2026, Canadian Nuclear Laboratories (CNL) announced an adjustment to its clean energy research program arrangements in order to direct more resources toward new nuclear projects currently under way and planned in Canada. CNL stated that, as of July 2026, it had terminated the Clean Energy Program Invitation and the Canadian Nuclear Research Initiative (CNRI). These two programs had previously been intended to leverage facilities and technical capabilities managed by CNL to support research, development, and demonstration of clean energy-related projects. CNL said the adjustment was made to optimize program priorities and concentrate efforts on supporting Canada's current and anticipated...

2026-09-11

Canada Supports IAEA "Rays of Hope" Initiative for the First Time, Will Provide Medical Isotope Training for Latin America

The Canadian Nuclear Isotope Council (CNIC) announced on September 10 that Canada has for the first time formally provided support to the International Atomic Energy Agency (IAEA) Rays of Hope initiative, and will help enhance cancer diagnosis and treatment capacity in Latin America through training in the production of medical radioisotopes and radiopharmaceuticals. The Rays of Hope initiative aims to expand access to cancer treatment and radiotherapy infrastructure in low- and middle-income countries. Under the arrangement, from November 8 to 14, 26 relevant sector leaders from Argentina, Brazil, Chile and Mexico will travel to Ontario, Canada, to participate in a training program jointly organized by Bruce Power and McMaster University. The training will focus on medical isotopes...

2026-09-11

Canada and UK Nuclear Institutes Sign Reciprocal Membership Agreement to Strengthen Nuclear Professional Cooperation

On September 8, 2026, the Canadian Nuclear Society (CNS) and the UK's Nuclear Institute (NI) announced the signing of a cooperation agreement at the Canada-UK Nuclear Day, establishing a reciprocal membership mechanism and promoting closer collaboration between the two professional organizations. Under the agreement, members of either organization can join the other free of charge and enjoy corresponding membership benefits, including registering for conferences and events hosted by the other organization at member discount rates. The arrangement aims to facilitate skills exchange, knowledge sharing, and professional networking between nuclear professionals in Canada and the UK, while supporting the career development of members in both countries. CNS President Daniel Gammage stated that the Canadian Nuclear Society is...

2026-09-09

Canada's AtomVie Opens Large-Scale Radiopharmaceutical R&D and Manufacturing Facility in Hamilton

On September 4, AtomVie Global Radiopharma, a radiopharmaceutical contract development and manufacturing organization, announced the official opening of its new state-of-the-art production facility at 10 Aeropark Boulevard, Hamilton, Ontario, Canada. The facility is designed to support the full-spectrum translation of radiopharmaceuticals from early-stage research and development, through clinical development, to commercial manufacturing. According to reports, the new facility represents an investment of over $160 million and spans 72,300 square feet, making it one of the largest single-site radiopharmaceutical R&D CDMO facilities in North America. The facility offers production capabilities ranging from low-throughput to high-throughput, increasing AtomVie's overall production capacity by more than tenfold, with dedicated spaces configurable to meet clients' subsequent R&D and commercialization needs.

2026-09-05

Canada's Devonian Integrates HPLC-MS, NMR, and Cell-Based Potency Assays into Thykamine Quality Control Platform

Devonian Health Group Inc., a Canadian clinical-stage biopharmaceutical company, recently announced that it has completed independent validation of key analytical methods and biological quality control technologies and integrated them into the extraction and production process of Thykamine, the company's lead active pharmaceutical botanical candidate. According to the company, its quality control program includes validated high-performance liquid chromatography-mass spectrometry (HPLC-MS) chemical fingerprinting, nuclear magnetic resonance (NMR) spectroscopy, and cell-based biological potency assays based on the U937 human cell line. The relevant cell-based assays use macrophage inflammatory protein-1β (MIP-1β) as a biomarker of Thykamine's anti-inflammatory activity...

2026-09-02

Defence Therapeutics Expands Radiopharmaceutical R&D Program to Evaluate Alpha and Beta Emitter Applications

MONTREAL, Quebec, Canada — Biotechnology company Defence Therapeutics Inc. recently announced the expansion of its radiopharmaceutical R&D program to include α and β radioisotopes in its evaluation scope, further validating the application potential of its proprietary Accum® technology in precision oncology. Defence Therapeutics is a publicly traded biotechnology company developing next-generation oncology treatments centered on its Accum® precision drug delivery platform. The company stated that the Accum® technology is designed to facilitate the entry of drug payloads into the intracellular compartment, thereby improving delivery efficiency. This expansion of the radiopharmaceutical program...

2026-09-01

Bruce Power Aims to Generate Over CAD 13.3 Billion in Economic Impact in Canada Over Next 18 Months

Bruce Power recently stated that over the next 18 months, the company expects to generate more than CAD 13.3 billion in economic impact across Canada, with related investments primarily stemming from its nuclear plant operations and life extension programs, supporting businesses and jobs in Ontario and other regions of Canada. Bruce Power stated that since launching the "Canada First" program in 2025, the company has invested over CAD 6.6 billion in Canada between January 2025 and June 2026, and plans to invest an additional CAD 7.7 billion by the end of 2027. The company noted that its spending within Canada accounts for more than 95% of total expenditures. As a nuclear operator located in Bruce County, Ontario...

2026-08-28

Canada's Nuclear Energy Strategy Focuses on Project Financing and Risk Sharing

The Canadian federal government recently unveiled a new nuclear energy strategy, explicitly committing to advancing new nuclear power projects nationwide, strengthening domestic supply chains, expanding uranium resources and nuclear fuel supply, and continuing to support nuclear technology innovation in fission and fusion. The strategy also states that nuclear deployment requires more modern financing tools, more efficient regulatory processes, and closer collaboration among governments, Indigenous communities, and industry. The goal of this strategy is to serve Canada's economic, social, and climate objectives through nuclear energy projects, enhancing national energy security while creating jobs and fostering innovation. As the strategic direction becomes clearer, how to translate policy goals into projects that are financeable and ready for construction has become the key question for the next phase.

2026-08-27

Canadian Light Source Synchrotron at University of Saskatchewan Receives $3 Million CAD in Upgrade Funding

On August 26, Innovation Saskatchewan announced that it will provide $3 million CAD in funding to the Canadian Light Source synchrotron at the University of Saskatchewan to support the installation of an advanced solid-state amplifier, advancing the facility's upgrade efforts. According to reports, this solid-state amplifier is a key component of the Canadian Light Source's core particle accelerator and will support the operation of its 22 synchrotron radiation beamlines. The upgrade is expected to enhance facility performance, operational reliability, and energy efficiency, further strengthening its capacity for cutting-edge scientific research. The Canadian Light Source is Canada's only synchrotron facility. Synchrotrons use electromagnetic fields and radiofrequency waves to accelerate electrons to near the speed of light, keeping them in a circular orbit; as electrons move, they generate high-brightness, highly focused synchrotron radiation beams, which are directed to different experimental beamlines to help researchers study material structures and properties at the atomic scale.

2026-08-27

IsoEnergy Signs Agreement with Kineepik Métis Local to Advance Uranium Exploration in Saskatchewan, Canada

On August 24, 2026, IsoEnergy Ltd. announced that it has signed an exploration agreement with Kineepik Métis Local Inc. to support its responsible uranium exploration activities in Saskatchewan, Canada. Under the agreement, the two parties will establish mechanisms for ongoing communication, information sharing, and collaboration around IsoEnergy's exploration activities in the relevant region. The agreement also provides that Kineepik community members and local businesses may participate in exploration-related work through business partnerships, employment opportunities, and training programs. Kineepik Métis Local Inc. represents Métis rights holders residing within the Kineepik use and occupancy area, including...

2026-08-26

Canada Approves Power Uprate for Bruce A and B Nuclear Power Plants

The Canadian Nuclear Safety Commission (CNSC) announced on August 24 that it has decided to amend the licensing basis for the Bruce A and B nuclear power plants, approving an increase in the intermediate power operating levels of the two plants. The Bruce A and B nuclear power plants are located in Kincardine, Ontario, Canada, on the eastern shore of Lake Huron, and are operated by Bruce Power. Under the revised licensing basis, Bruce Power may increase the maximum operating power of the Bruce A plant to 95.5% of full power and the Bruce B plant to 96% of full power. Previously, the Bruce A plant was authorized to operate at a maximum power of...

2026-08-26